Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 38%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Holdings Inc. demonstrated robust performance across its segments, with Home Health & Hospice revenue increasing by 27.3% year-over-year to $69.3 million, while gross margin expanded to 53.7%, surpassing target ranges. The Medical Solutions segment also showed significant growth, with revenue rising 21.3% to $52.5 million and gross margin improving markedly to 50.0%, aided by effective cash collections. Further, the Private Duty Services segment experienced a notable 28.1% year-over-year revenue increase driven by strong volume and rate growth, supported by positive contributions from the Thrive acquisition, which is set to enhance operational efficiencies.

Bears say

Aveanna Healthcare Holdings Inc. exhibits a concerning decline in financial performance characterized by a decrease in the Private Duty Nursing (PDN) spread rate, which fell to $12.12 from a previous range of $12.60, indicating ongoing wage pressures amid efforts to support higher service volumes. The organization faces numerous downside risks, including reimbursement pressures, difficulties in sourcing and integrating acquisitions, and substantial competition, all of which could affect future earnings and growth prospects. Additionally, adverse labor market conditions are projected to negatively influence adjusted EBITDA estimates by 10% for both FY26 and FY27, further compounding Aveanna’s financial challenges.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 38% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.